+

WO2007098183A3 - Traitement de cancer avec une 2-désoxygalactose - Google Patents

Traitement de cancer avec une 2-désoxygalactose Download PDF

Info

Publication number
WO2007098183A3
WO2007098183A3 PCT/US2007/004465 US2007004465W WO2007098183A3 WO 2007098183 A3 WO2007098183 A3 WO 2007098183A3 US 2007004465 W US2007004465 W US 2007004465W WO 2007098183 A3 WO2007098183 A3 WO 2007098183A3
Authority
WO
WIPO (PCT)
Prior art keywords
deoxygalactose
cancer
treatment
outcom
analogs
Prior art date
Application number
PCT/US2007/004465
Other languages
English (en)
Other versions
WO2007098183A2 (fr
Inventor
Bernard R Landau
Original Assignee
Bernard R Landau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard R Landau filed Critical Bernard R Landau
Priority to AU2007217764A priority Critical patent/AU2007217764A1/en
Priority to CA002655614A priority patent/CA2655614A1/fr
Priority to EP07751239A priority patent/EP2049125A2/fr
Publication of WO2007098183A2 publication Critical patent/WO2007098183A2/fr
Publication of WO2007098183A3 publication Critical patent/WO2007098183A3/fr
Priority to US12/196,195 priority patent/US20090163442A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne une 2-désoxygalactose et ses analogues utilisés pour traiter un cancer et améliorer le résultat chez un patient lorsque administrés thérapeutiquement, à des doses efficaces, seuls ou en combinaison avec un autre medicament antiéreux ou avec une résection chirurgicale ou une thérapie par rayonnement.
PCT/US2007/004465 2006-02-21 2007-02-21 Traitement de cancer avec une 2-désoxygalactose WO2007098183A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2007217764A AU2007217764A1 (en) 2006-02-21 2007-02-21 Treatment of cancer with 2-deoxygalactose
CA002655614A CA2655614A1 (fr) 2006-02-21 2007-02-21 Traitement de cancer avec une 2-desoxygalactose
EP07751239A EP2049125A2 (fr) 2006-02-21 2007-02-21 Traitement de cancer avec une 2-désoxygalactose
US12/196,195 US20090163442A1 (en) 2007-02-21 2008-08-21 Treatment of cancer with 2-deoxygalactose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77563006P 2006-02-21 2006-02-21
US60/775,630 2006-02-21

Publications (2)

Publication Number Publication Date
WO2007098183A2 WO2007098183A2 (fr) 2007-08-30
WO2007098183A3 true WO2007098183A3 (fr) 2007-12-13

Family

ID=38437961

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/004465 WO2007098183A2 (fr) 2006-02-21 2007-02-21 Traitement de cancer avec une 2-désoxygalactose

Country Status (5)

Country Link
EP (1) EP2049125A2 (fr)
CN (1) CN101437523A (fr)
AU (1) AU2007217764A1 (fr)
CA (1) CA2655614A1 (fr)
WO (1) WO2007098183A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264352A (en) * 1991-04-09 1993-11-23 Hoechst Aktiengesellschaft Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides
US5591429A (en) * 1993-07-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture Composition containing 2-deoxy-D-glucose and Candida saitoana and a method of use for the biological control of postharvest diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264352A (en) * 1991-04-09 1993-11-23 Hoechst Aktiengesellschaft Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides
US5591429A (en) * 1993-07-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture Composition containing 2-deoxy-D-glucose and Candida saitoana and a method of use for the biological control of postharvest diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] LASZLO ET AL.: "Effects of glucose analogs (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors", XP008138233, accession no. STN Database accession no. (1961:19261 *
JOURNAL OF THE NATIONAL CANCER INSTITUTE (1940-1978), vol. 24, 1960, pages 267 - 279 *
KO ET AL.: "Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase", CANCER LETTERS, vol. 173, 2001, pages 83 - 91, XP002365255 *

Also Published As

Publication number Publication date
AU2007217764A1 (en) 2007-08-30
EP2049125A2 (fr) 2009-04-22
CA2655614A1 (fr) 2007-08-30
CN101437523A (zh) 2009-05-20
WO2007098183A2 (fr) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2004062604A3 (fr) Traitement du cancer par le 2-desoxyglucose
WO2012045090A3 (fr) Utilisation thérapeutique d'un agoniste de tlr, et polythérapie
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
WO2004064734A3 (fr) Polytherapies anticancereuses
WO2011146777A3 (fr) Dispositif et procédé d'apport au cerveau de combinaison synergique de photothérapie et de modalité d'énergie non lumineuse
PH12013501790B1 (en) Use of dpp iv inhibitors
WO2007062093A3 (fr) Polytherapie pour le traitement du cancer
EP2759302A3 (fr) 4F-benzoyl-TN14003 combiné avec rituximab pour une utilisation dans le traitement d'une tumeure
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
WO2011041632A3 (fr) Thérapies combinées pour le traitement de l'obésité
WO2016090024A3 (fr) Polythérapie pour le traitement du cancer
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
WO2010019717A3 (fr) Thérapie de combinaison d'inhibiteurs de fusion/entrée du vih ciblant gp41
WO2007130501A3 (fr) Polythérapie pour traiter le cancer
HK1096023A1 (en) Combination therapy with azd2171 and 5-fu and/or cpt-11 azd2171?5-fu?cpt-11
BRPI0510895A (pt) formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t
WO2006124573A3 (fr) Traitement du cancer a l'aide de 2-desoxyglucose
WO2011009115A3 (fr) Thérapies combinées destinées à traiter l'obésité
TW200633700A (en) Methods of using temozolomide formulation intrathecally in the treatment of cancers
MX2009009230A (es) Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
ATE330600T1 (de) Kombinationspräparat zur krebstherapie
PL1732551T3 (pl) Perheksylina do leczenia przewlekłej niewydolności serca
WO2007098183A3 (fr) Traitement de cancer avec une 2-désoxygalactose

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007217764

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2655614

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2007217764

Country of ref document: AU

Date of ref document: 20070221

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200780009673.1

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2007751239

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载